CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for VIVA Biotech Holdings is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

VIVA Biotech Holdings
735 Ziping Road
Zhoupu Town, Pudong New District
Phone: +86 2160893288p:+86 2160893288 Shanghai, SHA  201318  China Ticker: 18731873
Business Summary
VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer Chen CheneyMao 62 7/3/2018 7/3/2018
Chief Financial Officer WeiXiong 40 9/27/2024 12/1/2023
Executive Vice President, Executive Director YingWu 61 7/3/2018 9/1/2009
9 additional Officers and Directors records available in full report.

Business Names
Business Name
1873
Synthesis Med Chem (Hong Kong)

General Information
Number of Employees: 2,063 (As of 12/31/2024)
Outstanding Shares: 2,131,775,305 (As of 3/27/2025)
Stock Exchange: HKG
Fax Number: +86 2158243936


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025